Michael S. Wyzga

US·SEC (Form 4)

X4 Pharmaceuticals, Inc LogicBio Therapeutics, Inc.Mereo BioPharma Group plc

Total declarations

Companies

▲ Purchases (1 ops.)

€27k

▼ Sales (0 ops.)

—

Latest filing published 10 Jun 2025 for X4 Pharmaceuticals, Inc. Read the official filing

Filing timeline

BuySale

Michael S. Wyzga

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

X4 Pharmaceuticals, Inc 1 purchase · last 22 Aug 2023

Michael S. Wyzga: trading record in brief

This profile gathers the share dealings of Michael S. Wyzga across 3 companies, led by X4 Pharmaceuticals, Inc, LogicBio Therapeutics, Inc. and Mereo BioPharma Group plc. Over a trading history stretching from 6 June 2022 to 9 June 2025, the count stands at 7 filings.

On the market, this insider has only ever bought: 1 purchase, €27k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants.

The newest entry dates from 10 June 2025: a share grant, in X4 Pharmaceuticals, Inc. The most recent open-market purchase was published on 22 August 2023, 1,153 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.